Get the Stockscreener App
15.62
0.22%
-0.02
Organon Co stock is traded at $15.62, with a volume of 635.84K.
It is down -0.22% in the last 24 hours and up +0.48% over the past month.
See More
Previous Close:
$15.60
Open:
$15.52
24h Volume:
635.84K
Relative Volume:
0.20
Market Cap:
$4.03B
Revenue:
$6.41B
Net Income/Loss:
$1.30B
P/E Ratio:
3.0992
EPS:
5.04
Net Cash Flow:
$646.00M
1W Performance:
+1.67%
1M Performance:
+0.48%
6M Performance:
-20.14%
1Y Performance:
-14.95%
1-Day Range:
$15.45
$15.65
1-Week Range:
$15.30
$15.88
52-Week Range:
$13.87
$23.10
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
15.62 | 4.03B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
841.61 | 754.10B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
210.01 | 374.57B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
76.93 | 338.61B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
163.46 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
MRK
Merck Co Inc
|
93.41 | 238.10B | 64.17B | 17.12B | 18.10B | 6.73 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Organon (OGN) Advances While Market Declines: Some Information for Investors - MSN
Why Organon Is A Top Pick For Income Investors (NYSE:OGN) - Seeking Alpha
Is Organon & Co. (OGN) the Deep Value Stock to Buy Now? - Insider Monkey
Organon & Co. (NYSE:OGN) Receives $20.80 Consensus Target Price from Analysts - Defense World
Organon & Co. (NYSE:OGN) Shares Sold by US Bancorp DE - Defense World
Organon & Co (OGN) Trading Down 2.88% on Mar 12 - GuruFocus.com
Organon’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia
Organon’s SWOT analysis: stock poised for growth amid challenges - Investing.com India
Trend Tracker for (OGN) - Stock Traders Daily
Proficio Capital Partners LLC Acquires New Holdings in Organon & Co. (NYSE:OGN) - Defense World
Healthcare Veteran Appointed CEO of May Health's Groundbreaking PCOS Technology - StockTitan
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older - BioSpace
MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO - Quantisnow
Organon announes results from analysis of Phase 3 ADORING 3 study - TipRanks
Can This Skin Treatment Work for Months After Stopping? New Clinical Data Reveals Surprising Results - StockTitan
Organon and Partners Advance Women’s Health Innovation to Drive Economic and Social Growth in Southeast Asia - The Hastings Tribune
Organon and partners drive innovation to strengthen healthcare access - Bangkok Post
Organon & Co. (NYSE:OGN) Shares Sold by Private Advisor Group LLC - Defense World
Truist Financial Corp Increases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World
(OGN) Long Term Investment Analysis - Stock Traders Daily
Principal Financial Group Inc. Raises Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Common Retirement Fund Buys 43,928 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Shares Up 5.7%Here's What Happened - MarketBeat
A&I Financial Services LLC Invests $402,000 in Organon & Co. (NYSE:OGN) - MarketBeat
Is Organon & Co. (OGN) the Best Low Price Pharma Stock to Invest In Right Now? - Insider Monkey
Rhumbline Advisers Sells 14,051 Shares of Organon & Co. (NYSE:OGN) - Defense World
Principal Financial Group Inc. Buys 32,485 Shares of Organon & Co. (NYSE:OGN) - Defense World
The Hidden Gems of the Pharma World: Stocks Analysts Can’t Ignore - jomfruland.net
Organon & Co. (OGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
10 Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
Allspring Global Investments Holdings LLC Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World
Savant Capital LLC Sells 88,315 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon's SWOT analysis: women's health leader faces biosimilar growth, LOE challenges - MSN
Organon announces departure of chief commercial officer - MSN
Philip James Wealth Mangement LLC Has $12.99 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):